Tolerability and safety with aducanumab in Alzheimer's disease in a community-based setting on a slower titration schedule. Devi G. J Am Geriatr Soc 2022 Oct 8. doi: 10.1111/jgs.18059.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Devi G. Tolerability and safety with aducanumab in Alzheimer's disease in a community-based setting on a slower titration schedule. J Am Geriatr Soc 2022 Oct 8. doi: 10.1111/jgs.18059.
PMID: 36208214